Biblio

Author Title [ Type

] Year

Filters: Author is Huang, Xiao-Jun [Clear All Filters]

Journal Article

Sun Y, Wang X, Chen W-M, Hao Y, Di Li L-, Li J-Y, Sun K, Shi Z-Y, Jiang H, Jiang Q, et al. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia. Hematol Oncol. 2024;42(2):e3264.

Mo X-D, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, Wang J-Z, et al. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction Chemotherapy. Biol Blood Marrow Transplant. 2016.

Zhao H-Y, Lyu Z-S, Duan C-W, Song Y, Han T-T, Mo X-D, Wang Y, Xu L-P, Zhang X-H, Huang X-J, et al. An unbalanced monocyte macrophage polarization in the bone marrow microenvironment of patients with poor graft function after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2018.

Niu L-T, Wang Y-Q, Wong CCL, Gao S-X, Mo X-D, Huang X-J. Targeting IFN-γ-inducible lysosomal thiol reductase overcomes chemoresistance in AML through regulating the ROS-mediated mitochondrial damage. Transl Oncol. 2021;14(9):101159.

Xue Y-J, Suo P, Huang X-J, Lu A-D, Wang Y, Zuo Y-X, Yan C-H, Wu J, Kong J, Zhang X-H, et al. Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post-remission treatment for children with very high-risk philadelphia chromosome negative B-cell acute lymphoblastic leukae. Br J Haematol. 2019.

Yu W-J, Wu Y, Liu J, Chen Y, Hou R-Q, Huang X-J, Jiang H. Successful management of a high-risk acute myeloid leukemia patient with severe coronary heart disease by venetoclax plus azacytidine and coronary artery bypass grafting. J Transl Int Med. 2024;12(1):119-122.

Wang J-Z, Huang X-J, Zhang Y-Y, Tang F-F, Han T-T, Mo X-D, Sun Y-Q, Chen Y-H, Wang Y, Zhang X-H, et al. Successful hematopoietic stem cell transplantation with haploidentical donors and non-irradiation conditioning in patients with Fanconi anemia. Chin Med J (Engl). 2021;134(20):2518-2520.

Qin Y-Z, Wang Y, Xu L-P, Zhang X-H, Zhao X-S, Liu K-Y, Huang X-J. Subgroup Analysis Can Optimize the Relapse Prediction Cutoff Value for WT1 Expression Following Allogeneic Hematologic Stem Cell Transplantation in Acute Myeloid Leukemia. J Mol Diagn. 2019.

Wang Y-Z, Hao L, Chang Y, Jiang Q, Jiang H, Zhang L-P, He L-L, Yuan X-Y, Qin Y-Z, Huang X-J, et al. A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype. Leuk Res. 2018;72:12-19.

Cao L-Q, Zhou J-R, Zhang X-H, Xu L-P, Wang Y, Chen Y-H, Chen H, Chen Y, Han W, Yan C-H, et al. A scoring system for predicting the prognosis of late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2021.

Ma R, Zhu D-P, Zhang X-H, Xu L-P, Wang Y, Mo X-D, Lv M, Zhang Y-Y, Cheng Y-F, Yan C-H, et al. Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experience. Bone Marrow Transplant. 2024.

Chen H, Xu L-P, Zhang X-H, Wang Y, Chen Y-H, Yan C-H, Cheng Y-F, Han W, Chen Y, Qin Y-Z, et al. Safety and outcomes of maintenance therapy with third-generation tyrosine kinase inhibitor after allogeneic hematopoietic cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia patients with T315I mutation. Leuk Res. 2022;121:106930.

Zhang Z-W, Zhao X-S, Guo H, Huang X-J. The role of mA demethylase FTO in chemotherapy resistance mediating acute myeloid leukemia relapse. Cell Death Discov. 2023;9(1):225.

Pei X-Y, Huang X-J. The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation. Expert Rev Clin Immunol. 2024;20(5):513-524.

Chang Y-J, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, Yan C-H, et al. Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody. Bone Marrow Transplant. 2020.

Chen Y, Xu L-P, Liu K-Y, Chen H, Chen Y-H, Zhang X-H, Wang Y, Wang F-R, Han W, Wang J-Z, et al. Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus. J Clin Virol. 2015;75:10-15.

Tang S-Q, Xing T, Lyu Z-S, Guo L-P, Liang M, Li C-Y, Zhang Y-Y, Wang Y, Xu L-P, Zhang X-H, et al. Repair of dysfunctional bone marrow endothelial cells alleviates aplastic anemia. Sci China Life Sci. 2023.

Zhang X-H, Wang G-X, Zhu H-H, Liu Y-R, Xu L-P, Han W, Chen H, Chen Y-H, Wang F-R, Wang J-Z, et al. Recruitment of CD8(+) T cells into bone marrow might explain the suppression of megakaryocyte apoptosis through high expression of CX3CR1(+) in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2015.

Tian D-M, Wang Y, Zhang X-H, Liu K-Y, Huang X-J, Chang Y-J. Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation. PLoS One. 2016;11(6):e0156777.

Hu L-J, Zhao X-Y, Yu X-X, Lv M, Han T-T, Han W, Huang X-J. Quantity and Quality Reconstitution of NKG2A NK cells Are Associated with Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2018.

Wang X-Y, Fan Q-Z, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, Wang F-R, Han W, Sun Y-Q, et al. The Quantification of Minimal Residual Disease Pre- and Post-Unmanipulated Haploidentical Allograft by Multiparameter Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia. Cytometry B Clin Cytom. 2019.

Sun K, Wang J, Wang Y-Z, Shi Z-Y, Chang Y, Yuan X-Y, Liu Y-R, Jiang H, Jiang Q, Huang X-J, et al. Prognostic significance of the frequencies of bone marrow lymphocyte subsets in adult acute myeloid leukemia at diagnosis. Int J Lab Hematol. 2023.

Wu P-H, Huo W-X, Mo X-D, Wang Y, Yan C-H, Jiang H, Shen M-Z, Huang X-J, An Y-Z. Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor. Ann Hematol. 2023.

Huang Q-S, Han T-X, Fu H-X, Meng H, Zhao P, Wu Y-J, He Y, Zhu X-L, Wang F-R, Zhang Y-Y, et al. Prognostic factors and outcomes in patients with septic shock after allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2023.

Liu S-N, Zhang X-H, Xu L-P, Wang Y, Yan C-H, Chen H, Chen Y-H, Han W, Wang F-R, Wang J-Z, et al. Prognostic factors and long-term follow-up of basiliximab for steroid-refractory acute GVHD: updated experienced from a large-scale study. Am J Hematol. 2020.

Pages